TGFBR2 and neoplasm: Similarly, Ostapoff et al. demonstrated that introducing a TGFβr2-neutralizing antibody was able to promote a differentiated tumor cell phenotype, and thus inhibit pancreatic cancer metastasis in the orthotopic human tumor xenografts [62].